Daniel Scherer

Heidelberg, BW 69120, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Verapamil inhibits Kir2.3 channels by binding to the pore and interfering with PIP2 binding.

Verapamil inhibits Kir2.3 channels by binding to the pore and interfering with PIP2 binding.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: August 22, 2022

Biological signalling supports biotechnology - Pulsed electric fields extract a cell-death inducing factor from Chlorella vulgaris.

Biological signalling supports biotechnology - Pulsed electric fields extract a cell-death inducing factor from Chlorella vulgaris.

Journal: Bioelectrochemistry (Amsterdam, Netherlands)

Published: July 15, 2021

Postcardiac injury syndrome after cardiac implantable electronic device implantation.

Postcardiac injury syndrome after cardiac implantable electronic device implantation.

Journal: Herz

Published: April 06, 2019

Unusual Primary Ocular Manifestation of Sarcoidosis.

Unusual Primary Ocular Manifestation of Sarcoidosis.

Journal: Case reports in ophthalmology

Published: March 10, 2019

Novel approach to discriminate left bundle branch block from nonspecific intraventricular conduction delay using pacing-induced functional left bundle branch block.

Novel approach to discriminate left bundle branch block from nonspecific intraventricular conduction delay using pacing-induced functional left bundle branch block.

Journal: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing

Published: May 16, 2018

Inhibition of inwardly rectifying Kir2.x channels by the novel anti-cancer agent gambogic acid depends on both pore block and PIP2 interference.

Inhibition of inwardly rectifying Kir2.x channels by the novel anti-cancer agent gambogic acid depends on both pore block and PIP2 interference.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: January 23, 2017

Dual Mechanism for Inhibition of Inwardly Rectifying Kir2.x Channels by Quinidine Involving Direct Pore Block and PIP2-interference.

Dual Mechanism for Inhibition of Inwardly Rectifying Kir2.x Channels by Quinidine Involving Direct Pore Block and PIP2-interference.

Journal: The Journal of pharmacology and experimental therapeutics

Published: October 13, 2016

Role of plasma membrane-associated AKAPs for the regulation of cardiac IK1 current by protein kinase A.

Role of plasma membrane-associated AKAPs for the regulation of cardiac IK1 current by protein kinase A.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: October 06, 2016

Inhibition of Cardiac Kir Current (IK1) by Protein Kinase C Critically Depends on PKCβ and Kir2.2.

Inhibition of Cardiac Kir Current (IK1) by Protein Kinase C Critically Depends on PKCβ and Kir2.2.

Journal: PloS one

Published: February 15, 2016

Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action.

Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action.

Journal: Drug design, development and therapy

Published: March 04, 2015

Inhibition of cardiac Kv1.5 potassium current by the anesthetic midazolam: mode of action.

Inhibition of cardiac Kv1.5 potassium current by the anesthetic midazolam: mode of action.

Journal: Drug design, development and therapy

Published: November 26, 2014

Class III antiarrhythmic drug dronedarone inhibits cardiac inwardly rectifying Kir2.1 channels through binding at residue E224.

Class III antiarrhythmic drug dronedarone inhibits cardiac inwardly rectifying Kir2.1 channels through binding at residue E224.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: May 26, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026